Psychedelics May Trigger Quantum Processes in Brain

A peer-reviewed article co-authored by NetraMark scientists proposes that psychedelics may not only alter brain chemistry but also engage quantum-level processes. Published in Frontiers in Pharmacology, the paper presents a testable hypothesis linking psychedelic effects to calcium signaling, phosphate metabolism, and spin-dependent molecular interactions. The research aims to address a key challenge in drug development: why individuals respond so differently to psychedelic treatments. NetraMark says the findings support its case for biomarker-guided patient selection, individualized response modeling, and AI-driven clinical trial design.